Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Birmingham, Alabama 35209


Purpose:

To examine the feasibility, acceptability, and preliminary impact of using NicoBloc compared to nicotine lozenges


Study summary:

Smoking remains the leading cause of preventable death in the U.S. with approximately 18% of the population continuing to smoke. However, smoking is concentrated in disadvantaged populations where the prevalence of smoking may be as high as 70-80 %. Participants will receive a sampling experience (use of nicotine lozenges or NicoBloc during sessions) with counseling focused around their experience of using these interventions, including side effects and smoking cessation expectancies.


Criteria:

Inclusion Criteria: 1. 18 years or older 2. planning to live in the Birmingham Metro area for the next 3 months 3. Smoking at least 5 cigarettes per day for the past year and a Carbon Monoxide>8ppm to ensure daily smoking. This relatively low cutoff was chosen due to the expectation of enrolling a large >50% African-American average <10 cigarettes per day compared to Whites who average ~15 cigarettes per day 4. exclusive use of filtered cigarettes 5. English speaking. Exclusion Criteria: 1. Living in a restricted environment that does not allow smoking (e.g., prison or jail facility, etc.) 2. Pregnant or nursing (all women of childbearing potential will be required to use an acceptable form of contraception) 3. Currently enrolled in a smoking cessation treatment program, using nicotine replacement products, or prescribed bupropion or varenicline 4. Known allergy nicotine lozenge 5. Within one month post-myocardial infarction or untreated severe angina 6. Cognitive impairment or unstable psychiatric condition that interferes with the informed consent process (individuals stable on psychiatric medications will be included) 7. Daily or exclusive use of other tobacco products (e.g., electronic cigarettes, little cigars, etc.).


NCT ID:

NCT03720899


Primary Contact:

Karen L Cropsey, Psy.D.
Phone: 2059757809
Email: kcropsey@uabmc.edu


Backup Contact:

Email: krc80@uab.edu
Keith Chichester, B.A.
Phone: 2059757809


Location Contact:

Birmingham, Alabama 35209
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.